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Abstract A new diagnostic strategy was assessed for the
routine diagnosis of intestinal parasites in returning travel-
lers and immigrants. Over a period of 13 months, unpre-
served stool samples, patient characteristics and clinical
data were collected from those attending a travel clinic.
Stool samples were analysed on a daily basis by micro-
scopic examination and antigen detection (i.e. care as
usual), and compared with a weekly performed multiplex
real-time polymerase chain reaction (PCR) analysis on
Entamoeba histolytica, Giardia lamblia, Cryptosporidium
and Strongyloides stercoralis. Microscopy and antigen
assays of 2,591 stool samples showed E. histolytica, G.
lamblia, Cryptosporidium and S. stercoralis in 0.3, 4.7, 0.5
and 0.1% of the cases, respectively. These detection rates
were increased using real-time PCR to 0.5, 6.0, 1.3 and
0.8%, respectively. The prevalence of ten additional
pathogenic parasite species identified with microscopy
was, at most, 0.5%. A pre-selective decision tree based on
travel history or gastro-intestinal complaints could not be
made. With increased detection rates at a lower workload
and the potential to extend with additional parasite targets
combined with fully automated DNA isolation, molecular
high-throughput screening could eventually replace micros-
copy to a large extent.
Introduction
Over the past decennia, outbound tourism showed a
worldwide increase and it is expected that this trend will
continue in the future [1]. As a consequence, it is likely that
a growing number of international travellers will consult a
doctor after their return. Gastro-intestinal disorders are one
of the main reasons for returning travellers to seek medical
advice [2, 3]. Moreover, several studies have shown that a
large proportion of travellers and immigrants from tropical
and subtropical countries harbour intestinal pathogens
without clear gastro-intestinal problems [4–7]. Although
this emphasises the need for a standard screening procedure
for all travellers, the increasing numbers of samples will
become a burden for routine diagnostic laboratories,
especially during the peak periods of holidaying. Patients
and diagnostic laboratories would, therefore, greatly benefit
from the implementation of a sensitive high-throughput
system for the screening of intestinal parasites.
Intestinal protozoan infections with Giardia lamblia and
Cryptosporidium hominis/Cryptosporidium parvum are the
main non-viral causes of diarrhoea in industrialised
countries [8] and are even more frequently seen as the
cause of gastro-intestinal complaints in returning travellers
[2, 9, 10]. Although quite rare, the early diagnosis of
Entamoeba histolytica is of vital importance because of the
potential invasive character of this protozoan parasite.
Intestinal helminth infections in travellers usually do not
cause severe clinical complications. One important excep-
tion is Strongyloides stercoralis. Unlike other helminth
infections, S. stercoralis is capable of maturing to the
infective filariform stage in the intestinal lumen, causing
auto-infection through larval penetration of the intestinal
mucosa or the perianal skin. Even after decades, these
chronic infections can develop into life-threatening hyper
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2000 Antwerp, Belgiuminfections in immune depressed patients, especially those
receiving immunosuppressive therapy with corticosteroids
[11]. Laboratory diagnosis of schistosomiasis, which is
frequently diagnosed in travellers, mainly depends on
serology rather than on the microscopic detection of ova
in stool and urine in this particular population [12].
Traditionally, the laboratory diagnosis of intestinal
protozoan and helminth infections relies on the detection
of trophozoites, cysts, eggs and larvae by microscopic stool
examination. Although microscopy is considered to be the
gold standard, it is labour-intensive and its diagnostic
performance critically depends on well-trained microscop-
ists. To improve sensitivity, multiple specimens and
concentration procedures, as well as a variety of staining
methods, are needed to achieve ample sensitivity [13, 14].
Enzyme immunoassays [15, 16] and direct fluorescent-
antibody assays [17] have been accepted as cost-effective
alternative diagnostic methods for the detection of G.
lamblia and Cryptosporidium in stools. The specific
detection of E. histolytica cannot be achieved using
microscopy alone, as cysts and (small) trophozoites of E.
histolytica and non-pathogenic E. dispar are morphologi-
cally indistinguishable. Therefore, additional methods such
as antigen detection or polymerase chain reaction (PCR)
have to be employed [7]. The laboratory diagnosis of S.
stercoralis is known to be problematic: the sensitivity and
specificity of immunodiagnostic assays can vary consider-
ably and the number of larvae in a stool sample can be very
low. Multiple samples and concentration methods such as
Baermann and copro-culture techniques are employed to
increase the detection rates [18].
Although DNA-based methods for a variety of intesti-
nal parasites have shown excellent sensitivity and speci-
ficity, until now, the introduction of these methods in
daily laboratory practice has been limited. The introduc-
tion of real-time PCR combining several targets into one
multiplex assay and the implementation of automated
DNA-isolation methods offers the possibility of using
DNA-based detection techniques in a high-throughput
diagnostic approach. In a previous study, it was shown
that in patients attending their general practitioner with
gastro-intestinal problems, only two parasitic pathogens
w e r ef o u n di ns u c hap o p u l a t i o n ,i . e .G. lamblia and C.
hominis/C. parvum [19]. The sensitivity of the multiplex
real-time PCR proved to be much higher as compared to
microscopy in detecting these two parasitic infections. In
returning travellers, a larger variety of parasitic infections
can be expected. Presently, one of the constraints of
multiplex real-time PCR is the restriction in the number of
parasitic targets that can be detected simultaneously.
Therefore, a careful assessment is needed for the choice
of parasitic targets when molecular diagnostic techniques
are implemented.
In this prospective study, the performance of real-time
PCR for the detection of E. histolytica, G. lamblia, C.
hominis/C. parvum and S. stercoralis DNA in faeces was
compared with current diagnostic tools, which consist of
microscopy and antigen detection in stool samples from
patients attending a travel clinic. Patient characteristics and
clinical data were recorded to define a practical diagnostic
strategy for the implementation of molecular methods in the
routine laboratory diagnosis of intestinal parasitic infections
in returning travellers and immigrants.
Materials and methods
Sample collection
Stool specimens were collected between April 2005 and
May 2006 from outpatients attending the travel clinic of the
Institute of Tropical Medicine (ITM) in Antwerp, Belgium.
Age, gender, place of birth, travel history and gastro-
intestinal complaints were actively recorded by the attend-
ing physician and included in the database. Patients who
were referred to the clinic specifically for HIV/AIDS-
related issues were not included in this study. A successive
sample from the same patient analysed within 30 days of
the preceding sample was excluded from the study.
Subsequently, each sample was considered to have been
obtained from a new patient. The protocol was approved by
the ethical committee of the ITM. Patients gave informed
consent and the data were rendered anonymous according
to the Belgian legislation.
Stool specimens were collected according to the routine
procedure of the ITM: patients were asked to fill an empty
tube with stool, preferably at the clinic, or otherwise to send
it to the diagnostic laboratory of the ITM by regular mail.
Aliquots of the samples were stored in the refrigerator until
they were sent to the Leiden University Medical Centre
(LUMC) for real-time PCR analysis on a weekly transport
by regular mail. Molecular diagnostics were performed
immediately after the arrival of the samples and the results
were generated blinded to the result of the conventional
stool examination at the ITM.
Microscopy and copro-antigen detection
Microscopic examination for the presence of ova and cysts
was performed daily according to the standard routine
procedures at the diagnostic laboratory of the ITM by the
examination of unstained and iodine-stained direct smears
with saline and unstained and iodine-stained wet mounts
after formalin-ether concentration [20]. Additionally,
carbol-fuchsine staining was performed on formalin-ether
concentrates for the detection of coccidian parasites [21].
1046 Eur J Clin Microbiol Infect Dis (2009) 28:1045–1053Both pathogenic and non-pathogenic parasites were
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Copro-antigen enzyme-linked immunosorbent assays
(ELISAs) for the detection of Giardia, Cryptosporidium
and E. histolytica/E. dispar (ProSpecT, Remel, Lenexa,
Kansas, USA) were performed on all specimens. The E.
histolytica-specific copro-antigen tests (TechLab, Blacks-
burg, VA, USA) was performed if microscopic examination
revealed E. histolytica/E. dispar cysts and/or if the E.
histolytica/E. dispar antigen ELISA showed a positive
result. In the diagnostic procedure at the ITM before the
start of this study, E. histolytica/E. dispar-positive samples
were routinely tested with the E. histolytica/E. dispar (HD)
PCR [22]. As in this study, E. histolytica PCR would be
performed as part of the E. histolytica/G. lamblia/Crypto-
sporidium (HGC) PCR on all samples; HD PCR was
performed only on the microscopy or antigen E. histolytica/
E. dispar-positive samples retrospectively.
In clinically suspected strongyloidiasis cases, Baer-
mann’s method was requested to detect S. stercoralis larvae
[23, 24]. The detection of Enterobius vermicularis eggs was
performed on demand using the scotch-tape method [25].
DNA isolation
For DNA isolation, 200μl of faeces suspension (approxi-
mately 0.5 g/ml PBS containing 2% polyvinylpolypyrroli-
done [PVPP; Sigma]) was heated for 10 min at 100°C. After
sodium-dodecyl-sulphate-proteinase K treatment (overnight
at 55°C), DNA was isolated with QIAamp Tissue Kit spin
columns (QIAgen, Hilden, Germany) [26]. In each sample,
10
3plaque-forming units (PFU)/ml phocin herpes virus 1
(PhHV-1) was added within the isolation lysis buffer, to
serve as an internal control for the isolation, amplification
and detection of the multiplex real-time PCR assays [27].
PCR amplification and detection
E. histolytica, G. lamblia and C. hominis/C. parvum
multiplex real-time PCR including PhHV-1 as an internal
control (HGC PCR) was performed as described previously
with some modifications [28]. S. stercoralis DNA amplifi-
cation was performed in a separate assay, also including
PhHV-1 as an internal control [29].
Amplification and detection reactions for HGC PCR were
performed in a volume of 25μl containing PCR buffer
(Hotstar master mix, QIAgen, Venlo, The Netherlands),
5m MM g C l 2,2 . 5 μg bovine serum albumin (BSA) (Roche
Diagnostics, Almere, The Netherlands), 3.13 pmol of each
E. histolytica-specific primer, 1.25 pmol VIC-labelled MGB
probe for E. histolytica (Applied Biosystems, Warrington,
UK), 3.13 pmol of each G. lamblia primer, 2.5 pmol G.
lamblia-specific FAM-double-labelled probe (Biolegio, Mal-
den, The Netherlands), 12.5 pmol of each C. hominis/C.
parvum-specific primer, 2.5 pmol of Texas Red double-
labelled probe for C. hominis/C. parvum,3 . 7 5p m o lo fe a c h
PhHV-1-specific primer, 2.5 pmol of PhHV-1-specific Cy5-
double-labelled probe [27]a n d5 μlo ft h eD N As a m p l e .
Amplification consisted of 15 min at 95°C followed by 50
cycles of 15 s at 95°C, 30 s at 60°C and 30 s at 72°C.
Amplification, detection and data analysis for HGC real-time
PCR was performed with the i-Cycler real-time detection
system (BioRad, Veenendaal, The Netherlands).
The amplification and detection of S. stercoralis-specific
DNA was performed with 5 pmol of each S. stercoralis-
specific primers, 2.5 pmol of S. stercoralis-specific FAM-
double-labelled probe (Biolegio), 3.75 pmol of each
PhHV-1-specific primer, 2.5 pmol of PhHV-1-specific Cy5-
double-labelled probe [27], PCR buffer (Hotstar master mix,
QIAgen), 5 mM MgCl2,2 . 5 μgB S Aa n d5 μlo ft h eD N A
sample in a final volume of 25μl[ 29]. Amplification
consisted of 15 min at 95°C followed by 50 cycles of 15 s
at 95°C and 60 s at 60°C. Amplification, detection and data
analysis for S. stercoralis real-time PCR was performed with
the Applied Biosystems 7500 Real-Time PCR System and
Sequence Detection Software version 1.2.2.
At the end of the study period, E. histolytica/E. dispar-
positive samples with microscopy- and/or copro-antigen
detection HD PCR [22] was performed, retrospectively.
Amplification and detection was performed with 3.125 pmol
of each E. histolytica/E. dispar-specific primers, 2.5 pmol
of E. dispar-specific FAM-labelled MGB probe (Applied
Biosystems) [22], 3.75 pmol of each PhHV-1-specific
primer, 2.5 pmol of PhHV-1-specific Cy5-double-labelled
probe [27], PCR buffer (HotStar master mix, QIAgen),
5 mM MgCl2, 2.5μg BSA and 5μl of the DNA sample in a
final volume of 25μl. Amplification consisted of 15 min at
95°C, 30 s at 60°C and 30 s at 72°C. Amplification,
detection and data analysis for HD real-time PCR was
performed with the i-Cycler real-time detection system.
High cycle threshold values (Ct-values) obtained by real-
time PCR are considered to be less reproducible due to very
low copy numbers of the specific target. Therefore, the
PCR of samples revealing Ct-values above 36 were
repeated. Also, the amplification was considered to be
hampered by faecal inhibitory factors if the expected Ct-
value of 33 in the PhHV-1-specific PCR was increased with
more than 3.3 cycles. Samples were recorded negative for
the specific target if the positive (high) Ct-value could not
be reproduced or were excluded if the amplification
remained inhibited.
Data analysis
The results of the microscopic examinations, copro-antigen
tests and real-time PCR analysis were stored and grouped in
Eur J Clin Microbiol Infect Dis (2009) 28:1045–1053 1047an Access database (Microsoft, Redmond, WA, USA). Data
included patient’s demographic information, travel history
and clinical presentation, the laboratory results of the travel
clinic in Antwerpen and the real-time PCR results of the
laboratory for parasitology in Leiden. Travel destinations
were classified according to geographical regions: Central
America, South America, Asia, Northern Africa and sub-
Saharan Africa were considered as high-risk areas and
others (including Europe, United States of America and
Australia) as being at a low risk of contracting intestinal
infections. World travellers or sailors were also considered
to have a high risk of contracting intestinal infections.
Analysis was done with SPSS 14.0 (SPSS Inc., Chicago,
IL, USA). Continuous variables were described by the
range and median of all positive cases and were compared
between groups by the Mann-Whitney rank-sum test. For
this purpose, zero values in Ct-values were redefined as 50.
Statistical significance was considered at P<0.05. The Chi-
square distribution for the risk of acquiring pathogenic
intestinal parasites, recorded as high- or low-risk travel
destination, or for the presence of gastro-intestinal com-
plaints, was calculated as a proportion of parasite infections
detected by any of the used diagnostic techniques.
Results
Study group
Over a period of 13 months, 2,709 samples were collected
and analysed (Fig. 1). One hundred and eighteen samples
were excluded from the study population as the time
interval after the preceding sample of the same patient
was less than 30 days. The final number of participants
included in this study was 2,591. PhHV internal control was
amplified within the correct Ct range in all samples;
therefore, no samples were excluded due to inhibition.
The travellers’ ages varied from newborn to 85 years
(median 36) and 55.5% of the patient cohort was of the
male gender. Travel to 142 different countries or areas was
mentioned, most frequently to sub-Saharan Africa (50.9%).
The majority of travellers were born in Europe (73.7%) or
on the African continent (19.0%). Gastro-intestinal com-
plaints were mentioned by 897 (34.6%) patients and are
listed in more detail in Table 1, together with the other
patient’s characteristics.
Diagnosis of Entamoeba histolytica/Entamoeba dispar,
Giardia lamblia and Cryptosporidium spp.
The results of microscopy, copro-antigen and real-time
PCR for all faecal parasites are summarised in Table 2. E.
histolytica/E. dispar cysts and trophozoites were detected
by microscopy in 99 cases. Fifteen additional cases were
detected with E histolytica/E. dispar copro-antigen ELISA.
The presence of E. histolytica was confirmed with the
species-specific copro-antigen ELISA in seven cases. In
one of these seven samples, trophozoites with ingested red
blood cells were seen in the direct smear, representing the
only distinctive morphologic features of E. histolytica. E.
histolytica-specific amplification was detected using the
HGC PCR in 13 samples, with Ct-values between 20.7 and
38.7 (median 31.3). Retrospective analysis with HD PCR of
114 E. histolytica/E. dispar microscopy and/or copro-
antigen-positive samples confirmed 88 samples as E. dispar
and 14 samples as E. histolytica,w h e r e a sH DP C R
remained negative for both targets in 12 samples.
G. lamblia cysts and/or trophozoites were detected with
microscopy in 95 cases and 121 cases revealed a positive
result in the Giardia antigen ELISA. The Giardia antigen
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Fig. 1 Number of all collected
stool samples (n=2,709) on a
weekly basis between April
2005 and May 2006. Sharp
increases of sample collections
due to holidays are observed in
August 2005 and at beginning
of January 2006
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did not confirm two microscopy-positive samples. G.
lamblia-specific amplification was detected in 149 samples
with Ct-values between 17.0 and 44.7 (median 29.8).
Cryptosporidium oocysts were detected in 12 carbol-
fuchsine-stained samples. The copro-antigen tests con-
firmed all Cryptosporidium microscopy-positive samples
and two additional samples were found positive in the
Cryptosporidium antigen ELISA. C. hominis/C. parvum-
specific amplification was detected in 31 samples with Ct-
values between 24.4 and 39.5 (median 35.6).
Ct-values of samples positive with microscopy and/or
copro-antigen tests were significantly lower as compared to
samples with a negative result in the conventional methods
(P < 0.001) for both G. lamblia and C. hominis/C. parvum
(data not shown).
Discrepancies between real-time HGC PCR and conven-
tional methods were observed in the following cases. E.
histolytica real-time PCR was negative in one sample in
which E. histolytica/E. dispar cysts were observed with
microscopy and both copro-antigen ELISAs tested positive.
Giardia real-time PCR remained negative in two cases in
which cysts were seen in microscopy and in five cases in
which only the copro-antigen assay tested positive. Cryp-
tosporidium real-time PCR remained negative in two
samples in which only the Cryptosporidium copro-antigen
tested positive. The HGC multiplex real-time PCR detected
a total of 49 additional cases which were not detected with
microscopy and antigen tests.
Strongyloides stercoralis
Rhabditiform S. stercoralis larvae were detected with
microscopy on concentrated smears in three samples. In
one of these samples, the number of larvae was exception-
ally high and the larvae were also detected in direct smear.
Baermann’s method was performed on stool samples from
121 clinically suspected cases and was only found to be
positive in the same sample that was found to be positive in
the direct smear. S. stercoralis-specific amplification was
detected in all three microscopy-positive samples and in 18
additional samples with Ct-values ranging from 24.5 to
39.5 (median of 33.3).
Other parasitic infections
Microscopy revealed 55 additional pathogenic parasites that
were not targeted with real-time PCR. Mixed infections
with two pathogenic parasite species were observed in 18
patients (Table 3). Non-pathogenic parasites as seen in
direct smears and wet mounts after concentration are also
summarised in Table 2.
Travel history, symptoms and intestinal parasites
Detected parasitic infections in relation to travel destination
and gastro-intestinal complaints are summarised in Table 4.
Table 1 Epidemiological and clinical characteristics of the study
population (n=2,591)
Characteristics n (%)
Patient characteristics
Male 1,437 (55.5)
Age range, median, years 0–85 (36.0)
Children, age <15 years 161 (6.2)
Elderly, age >59 years 259 (10.0)
Born in Europe 1,910 (73.7)
Born in Africa 491 (19.0)
Other/unknown country of birth 190 (7.4)
Last visited region
Low-risk areas 98 (3.8)
Central America 99 (3.8)
South America 130 (5.0)
Asia 458 (17.7)
North Africa 102 (3.9)
Sub-Saharan Africa 1,318 (50.9)
World travellers 17 (0.7)
Unknown 369 (14.2)
In Belgium since
<1 month 1,143 (44.1)
1–6 months 579 (22.3)
6–12 months 170 (6.6)
>12 months 476 (18.4)
Unknown 223 (8.6)
Gastro-intestinal complaints
No gastro-intestinal complaints 1,692 (65.3)
Diarrhoea, flatulence, pain and/or nausea 897 (34.6)
Unknown 2 (0.1)
Gastro-intestinal complaints specified
Diarrhoea 635 (24.5)
Flatulence 380 (14.7)
Cramps/pain 608 (23,5)
Nausea 280 (10,8)
Duration of complaints
<2 weeks 334 (12.9)
>2 weeks 563 (21.7)
Stool consistency
Formed 1,765 (68.1)
Unformed 765 (29.5)
Watery 49 (1.9)
Unknown 12 (0.5)
Bloody 37 (1.4)
Mucous 1 (<0.1)
Eur J Clin Microbiol Infect Dis (2009) 28:1045–1053 1049The majority (69.2%) of the study participants travelled to
areas where the exposure risk to intestinal parasites is
considered to be high. Among those with high-risk travel
destinations, infection rates were not significantly higher
for any of the pathogenic parasites compared with those
who travelled to low-risk areas. Gastro-intestinal com-
plaints were correlated with G. lamblia- and C. hominis/C.
parvum detection (P<0.001), but not with the detection of
E. histolytica, S. stercoralis or other pathogenic parasitic
infections.
Discussion
The diagnosis of intestinal parasitic infections in returned
travellers traditionally relies on time-consuming analyses
by experienced microscopists. Nowadays, the increasing
number of travellers to a variety of exotic countries calls for
new diagnostic approaches for the efficient processing of
samples. In this study, multiplex real-time PCR was
compared with the routine approach of microscopy and
antigen-based methods, focussing on four target parasites, E.
histolytica, G. lamblia, Cryptosporidium and S. stercoralis,
respectively.
The results showed PCR to be more sensitive for the
specific detection of E. histolytica, G. lamblia, C. hominis/
C. parvum and S. stercoralis. Only a few unexplained
discrepancies between the different detection methods were
seen. These were mostly cases in which only the antigen
test was positive. In one sample, E. histolytica/E. dispar
cysts were seen with microscopy and both antigen ELISAs
Pathogens Total detected Microscopy
a Antigen Real-time PCR
E. histolytica/E. dispar 114 99 90
c -
E. histolytica 14 1
b 7
d 13
G. lamblia 156 95 121 149
Cryptosporidium spp. 33 12 14 31
S. stercoralis 21 3 - 21
T. trichiura 14 14 - -
Hookworm 10 10 - -
A. lumbricoides 88 - -
Trichostrongylus spp. 3 3 - -
E. vermicularis 11 - -
S. mansoni 11 11 - -
S. haematobium 11 - -
Taenia spp. 1 1 - -
C. cayetanensis 44 - -
I. belli 22 - -
Non-pathogens
E. coli 246 246 - -
B. hominis 220 220 - -
E. nana 139 139 - -
E. hartmanii 59 59 - -
I. butschlii 26 26 - -
C. mesnilii 23 23 - -
S. hominis 66 - -
Table 2 Intestinal parasites in
the study population (n=2,591)
as detected with microscopy,
copro-antigen test and real-time
polymerase chain reaction
(PCR)
aDirect microscopy, after
formalin-ether concentration,
scotch tape test for E.
vermicularis, Baermann test for
S. stercoralis, and carbol-
fuchsine staining for Crypto-
sporidium spp.
bObserved hematophagous
trophozoites
cE. histolytica / E. dispar copro-
antigen test (ProSpect, Remel,
Lenexa, Kansas, USA)
dE. histolytica specific copro-
antigen test (TechLab,
Blackburg, Virginia, USA)
Table 3 Observed double infections of pathogenic parasites in stool
samples (n=2,591), detected by microscopy, copro-antigen detection
and/or real-time PCR
Combination of species found Number of samples
E. histolytica and G. lamblia 1
E. histolytica and Cryptosporidium spp. 1
E. histolytica and Hookworm 1
G. lamblia and Cryptosporidium spp. 4
G. lamblia and S. stercoralis 2
G. lamblia and T. trichiura 2
G. lamblia and Trichostrongylus spp. 1
Cryptosporidium spp. and T. trichiura 1
S. stercoralis and A. lumbricoides 1
A. lumbricoides and E. vermicularis 1
A. lumbricoides and hookworm 1
Hookworm and T. trichiura 1
Trichostrongylus spp. and S. mansoni 1
1050 Eur J Clin Microbiol Infect Dis (2009) 28:1045–1053showed a positive result; however, E. histolytica-specific
amplification was not successful in the initial HGC PCR. A
positive result was obtained when the HGC real-time PCR
was repeated, as well as in the HD real-time PCR. Internal
and positive controls in the initial real-time PCR analysis
were correct and the reason for the negative outcome of the
first real-time PCR analysis remains unclear. This one case
is discordant with the proven higher sensitivity of E.
histolytica real-time PCR compared to stool antigen assays
in a non-endemic setting [30, 31].
It is well known that the laboratory diagnosis of S.
stercoralis requires multiple fresh stool samples using
concentration techniques and/or copro-culture in order to
improve detection rates [32]. In this study, the Baermann
concentration technique was requested by the clinician in
case of clinical suspicion, yet many Baermann tests were
omitted because, for example, the sample was too old (had
been sent by mail). Although the positive results of the S.
stercoralis real-time PCR was confirmed by microscopy in
three cases only, the other positive results were supported
by serology (n=7), eosinophilia (n=5) and/or clinical
presentation (n=4) in the majority of cases.
In this study population, ten additional pathogenic
parasite species detected by microscopy were missed with
only four targeted parasite species in the real-time PCR.
However, the prevalence of each detected species was only
0.5% at most and the clinical significance of the majority of
these parasitic infections is limited. Most of these infections
were helminths, of which the eggs could be easily found
with microscopy at low magnification of an unstained wet
mount of the concentrated sample. Schistosomiasis is
probably the most relevant and also probably the most
underestimated infection in this study, as the laboratory
diagnosis of Schistosoma infections in travellers relies
mainly on serology [33]. The implementation of a Schisto-
soma real-time PCR [34] might be a worthwhile addition to
a molecular diagnostic panel; however, its performance in a
routine setting still needs further evaluation. Finally, two
remaining protozoan infections, Isospora belli and Cyclo-
spora cayetanensis, are important candidates as additional
real-time PCR targets for patients returning from high-risk
areas [35–37].
Designing an efficient diagnostic strategy requires a
thorough exploration of possible predictors for parasite
exposure in patient groups. A rationale for a specific
diagnostic approach in a travel population is less evident
compared with a patient group without extensive travel
background [19]. In the travel population of this study, only
a minority (34.6%) mentioned gastro-intestinal complaints.
Stool examination was also performed as part of a routine
screening procedure. The presence of gastro-intestinal
complaints was a significant predictor only for the presence
of G. lamblia and C. hominis/C. parvum. In the cases
without complaints, however, the prevalence of G. lamblia
was still higher than any of the other pathogenic parasites in
the total population. Furthermore, travel destinations were
of little predictive value for the presence of any of the
parasitic infections. In conclusion, travel destinations or
gastro-intestinal complaints did not provide a diagnostic
key towards specific pathogenic parasites in this study. As
already seen in other studies, an exception can be made for
the diagnosis of schistosomiasis, as cases are mainly found
in travellers returning from Africa [6, 33].
The overall low prevalence of intestinal parasitic
infections found in this study emphasises the need for a
rapid, sensitive and simple screening assay for the most
important parasitic infections in all returned travellers,
disregarding their travel history and the presence of
gastro-intestinal complaints, which agrees with recommen-
dations made in other studies [6, 38, 39]. The low
Table 4 Detected intestinal parasites in the study population (n=2,591) by real-time PCR, microscopy and/or antigen test listed in numbers and
proportion of travel destination or the presence of gastro-intestinal (GI) complaints
PCR/microscopy/ag Microscopy
E. histolytica G. lamblia Cryptosporidium S. stercoralis additional pathogenic parasites
High-risk travel pop.
a, n=1,793 (100%) 10 (0.6%) 121 (6.7%) 26 (1.5%) 16 (0.9%) 37 (2.1%)
Low-risk travel pop.
b, n=429 (100%) 3 (0.7%) 19 (4.4%) 4 (0.9%) 1 (0.2%) 4 (0.9%)
Destination unknown, n=369 (100%) 1 (0.3%) 16 (4.3%) 3 (0.8%) 4 (1.1%) 14 (3.8%)
With GI complaints, n=897 (100%) 7 (0.8%) 76 (8.5%) 25 (2.8%) 4 (0.4%) 18 (2.0%)
No complaints, n=1,694 (100%)
c 7 (0.4%) 80 (4.7%) 8 (0.5%) 17 (1.0%) 37 (2.2%)
d
Total, n=2,591 (100%) 14 (0.5%) 156 (6.0%) 33 (1.3%) 21 (0.8%) 55 (2.1%)
aSub-Saharan Africa, Asia, world travellers
bEurope, America, Australia, North Africa
cTwo cases with complaints not registered are added to the traveller group without gastro-intestinal complaints
dGroup contains four travellers with double infections
Eur J Clin Microbiol Infect Dis (2009) 28:1045–1053 1051prevalence of additionally detected parasites raises doubts
about the cost benefit of elaborate microscopic analyses of
stool samples. An in-depth study on the cost per detected
parasite or profit per diagnosis by different technical
approaches will further elucidate the most beneficial
strategy for a laboratory. For example, the staff utilisation
for stool analysis with conventional techniques consists in
this study of approximately one full-time equivalent (FTE)
compared to 0.3 FTE for stool DNA isolation and real-time
PCR analysis. Moreover, a fully automated DNA isolation
process and extension of additional molecular targets on the
already isolated DNA will have considerable impact on the
cost-efficiency of the diagnostic procedures. Already, a
growing number of routine diagnostic laboratories are
implementing multiplex real-time PCR for the detection of
intestinal microorganisms [19, 40, 41]. These standard PCR
assays can be extended specifically for the travel population
with one or more additional multiplex real-time PCR panels
for an overlap of the most important intestinal parasitic
infections.
Real-time PCR has proved to be a highly sensitive and
specific technique for the detection of the majority of
intestinal parasites found in returning travellers presenting
at a travel clinic with and without gastro-intestinal
complaints. The diagnostic approach for the detection of
intestinal parasites in returning travellers in a routine
diagnostic laboratory could be limited to real-time PCR
for E. histolytica, G. lamblia, Cryptosporidium spp. and S.
stercoralis. In addition, Schistosoma serology should be
performed for travellers to Africa [6]. This approach could
be complemented with additional multiplex PCRs and/or a
quick microscopic examination for the presence of helminth
eggs. Fully automated procedures and combination with
additional targets might replace microscopy in the future to
a large extent.
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